Pharmacovigilance

Consumers and healthcare professionals are encouraged to report any adverse drug reactions.

You can report a suspected adverse drug reaction following the use of Bichsel products directly to Swissmedic at: https://nebenwirkung-melden.swissmedic.ch/meldende-person.php or, depending on the product, to one of the following companies:

Product Name

as of (date)

Reporting office

Phoscap, Kapseln

October 01, 2026

Verfora AG
Email: vigilance@verfora.ch

Adrenalin «Bichsel» Injektionslösungen
Heparin «Bichsel» 100 I.E./ml Injektionslösung
Heparin «Bichsel» 417 I.E./ml, Infusionslösung und 1000 I.E./ml, 5000 I.E./ ml Injektionslösung
Magnesiumsulfat «Bichsel» Injektionslösung
Morphin HCl «Bichsel» Injektionslösung
Soin de bouche «Bichsel» Mundspüllösung

October 15, 2026

Streuli Pharma AG
Email: vigilance@streuli-pharma.ch
or
https://streuli-pharma.ch/meldung-nebenwirkungen/

Bichsel approved medicinal products, except Streuli Pharma AG (see above)

November, 01 2026

Verfora AG
Email: vigilance@verfora.ch

For all other Bichsel products, please contact Verfora AG's customer service department: 
Email: kundendienst@verfora.ch
Phone: +41 58 857 93 00